| pubmed-article:21246521 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0239307 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0029246 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0035168 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C1335110 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0205618 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0081527 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:21246521 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:21246521 | pubmed:issue | 13 | lld:pubmed |
| pubmed-article:21246521 | pubmed:dateCreated | 2011-6-21 | lld:pubmed |
| pubmed-article:21246521 | pubmed:abstractText | Although it has been demonstrated that the neuronal intermediate filament alpha-internexin (INA) is closely related to 1p19q codeletion in gliomas, its prognostic and predictive value has not yet been confirmed in a prospective trial. The authors of this report assessed the prognostic significance of INA expression and its correlation with relevant clinical and molecular characteristics in the prospective, randomized European Organization for Research and Treatment of Cancer (EORTC) 26951 trial of adjuvant procarbazine, lomustine, and vincristine (PCV) in patients with anaplastic oligodendroglial tumors (AOTs). | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21246521 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21246521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21246521 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21246521 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:21246521 | pubmed:issn | 1097-0142 | lld:pubmed |
| pubmed-article:21246521 | pubmed:author | pubmed-author:WesselingPiet... | lld:pubmed |
| pubmed-article:21246521 | pubmed:author | pubmed-author:SansonMarcM | lld:pubmed |
| pubmed-article:21246521 | pubmed:author | pubmed-author:KrosJohan MJM | lld:pubmed |
| pubmed-article:21246521 | pubmed:author | pubmed-author:Hoang-XuanKhe... | lld:pubmed |
| pubmed-article:21246521 | pubmed:author | pubmed-author:GorliaThierry... | lld:pubmed |
| pubmed-article:21246521 | pubmed:author | pubmed-author:MokhtariKarim... | lld:pubmed |
| pubmed-article:21246521 | pubmed:author | pubmed-author:TaphoornMarti... | lld:pubmed |
| pubmed-article:21246521 | pubmed:author | pubmed-author:Van den... | lld:pubmed |
| pubmed-article:21246521 | pubmed:author | pubmed-author:IdbaihAhmedA | lld:pubmed |
| pubmed-article:21246521 | pubmed:author | pubmed-author:DucrayFrançoi... | lld:pubmed |
| pubmed-article:21246521 | pubmed:copyrightInfo | Copyright © 2011 American Cancer Society. | lld:pubmed |
| pubmed-article:21246521 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21246521 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:21246521 | pubmed:volume | 117 | lld:pubmed |
| pubmed-article:21246521 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21246521 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21246521 | pubmed:pagination | 3014-26 | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:meshHeading | pubmed-meshheading:21246521... | lld:pubmed |
| pubmed-article:21246521 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21246521 | pubmed:articleTitle | Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951. | lld:pubmed |
| pubmed-article:21246521 | pubmed:affiliation | Mixed Research Unit, UMR 975, INSERM, National Institute of Health and Medical Research-Pierre and Marie Curie University, Pitie-Salpetriere Group Hospital, Paris, France. | lld:pubmed |
| pubmed-article:21246521 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21246521 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21246521 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
